Clinical Trials Browser

Phase 3 × Nasopharyngeal Neoplasms × Chemotherapy, Adjuvant × Clear all

NCT00370890 2022-02-17

A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Phase 3 Completed

Nasopharyngeal Neoplasms